David Shering

Title: David Shering: Innovator in Soft Connective Tissue Compositions

Introduction

David Shering is a notable inventor based in Manchester, GB. He has made significant contributions to the field of tissue engineering, particularly in the development of methods for forming soft connective tissue compositions, such as skin equivalents. His innovative approach has the potential to advance medical treatments and improve patient outcomes.

Latest Patents

David Shering holds a patent for a method titled "Skin Equivalent Culture." This patent outlines a comprehensive process for creating connective tissue equivalents. The method involves incubating collagen-producing cells on a support matrix, enhancing collagen production, freeze-drying the construct, and re-populating it with various cell types. This innovative technique allows for the replacement of provisional fibrin matrices with collagen matrices synthesized in situ by the cells. He has 1 patent to his name.

Career Highlights

David Shering is associated with DFB Technology Holdings, LLC, where he continues to push the boundaries of tissue engineering. His work focuses on developing advanced methods that can be utilized in regenerative medicine. His expertise in collagen production and tissue composition has positioned him as a key figure in this innovative field.

Collaborations

David collaborates with professionals such as Paul Kemp and Andrew Shering, who contribute to his research and development efforts. Their combined expertise enhances the potential for breakthroughs in tissue engineering.

Conclusion

David Shering's contributions to the field of soft connective tissue compositions exemplify the impact of innovative thinking in medical science. His patent for skin equivalent culture represents a significant advancement in regenerative medicine.